Preclinical and clinical data indicate cooperative oncogenic activity between MCM7 and its hosted miRNAs: overexpression of MCM7 is frequently accompanied by upregulation of miR-106b-5p and its sibling miRNAs, contributing to proliferation, evasion of apoptosis and therapeutic resistance across several cancer types. The gene discussed is MCM7; the disease is cancer.